Effectiveness of Feeding Tubes Among Person with Advanced Cognitive Impairment

饲管对晚期认知障碍患者的有效性

基本信息

  • 批准号:
    7846356
  • 负责人:
  • 金额:
    $ 34.11万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-09-30 至 2011-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Effectiveness of Feeding Tubes Among Persons with Advanced Cognitive Impairment This application addresses broad challenge area (05) Comparative Effectiveness Research, Challenge Topic 05-AG-101: Data Infrastructure for Post-Marketing Comparative Effectiveness Studies. Advanced dementia is a common life-defining illness with a disease trajectory of eating problems, weight loss, and recurrent infections. The current use of percutaneous endoscopic gastronomy (PEG) feeding tubes in persons with advanced cognitive impairment raises two concerns. First, there is striking variation in use by states, hospital referral regions, and hospitals. This variation is in contrast to the widely cited interpretation of the existing observational data that questions the effectiveness of feeding tubes in persons with dementia. Second, this evidence base itself is imperfect. These studies rely on observational data, yet none have attempted to control for selection bias, a potential problem in any non- randomized controlled trial. Furthermore, with only two exceptions, this work has not adequately adjusted for confounders. Two recent studies have found dementia not to be an independent predictor of survival with a corresponding editorial calling for better outcomes data to judge the efficacy of feeding tubes in persons with dementia. Our previous research and preliminary studies have found that hospitals are a key locus of care and final site of decision making for feeding tube insertions among the elderly with advanced dementia. We have found that the majority of PEG feeding tube decisions are made during an acute care hospitalization for an infection, and the rate at which hospitals insert PEG feeding tubes varies from 0% to 31% of hospital admissions of nursing home residents with advanced cognitive impairment. The proposed research has two overarching goals. First, we aim to use advanced methods to account for selection bias to provide a more definitive study of the potential benefits (survival, weight change, prevention and healing of pressure ulcers), risks (use of restraints, prescription of antipsychotics or benzodiazepines, and transitions to the ER and acute care hospital), and health care expenditures. This goal will be accomplished through the linkage of four files (Medicare Claims, Minimum Data Set, American Hospital Association data, and Dartmouth Atlas of Health Care) from 1999-2008 and Medicare Part D data from 2006-2008. This analysis will examine individual-level results among persons with advanced cognitive impairment, as well as persons who receive their medical care at institutions with varying rates of PEG feeding tube insertion. A second goal is to understand the variation in hospital insertion rates of PEG feeding tubes. In this goal, we will examine potentially modifiable hospital characteristics, market factors, and state policies associated with this variation in hospitals' rate of PEG feeding tube insertion. Knowledge gained will be used to inform public policy and formulate hospital-based interventions to ensure that PEG tube insertion in persons with advance cognitive impairment is ethically appropriate and consistent with the best available data on their effectiveness. Eating problems are common issues with persons afflicted with dementia. There are two concerns with the use of feeding tubes. First, hospitals vary in their rate of feeding tube insertion despite two widely cited reviews of the evidence that question the effectiveness of feeding tubes. Second, there is controversy about the evidence of effectiveness of feeding tubes. The proposed research will provide authoritative evidence of the effectiveness of feeding tubes and identify modifiable hospital characteristics and state policies that account for the observed striking variation in feeding tube use.
描述(由申请人提供):

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOAN M TENO其他文献

JOAN M TENO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOAN M TENO', 18)}}的其他基金

Invasive and Non-Invasive Mechanical Ventilation Outcomes in Advanced Dementia
晚期痴呆症的侵入性和非侵入性机械通气效果
  • 批准号:
    10017826
  • 财政年份:
    2019
  • 资助金额:
    $ 34.11万
  • 项目类别:
The Revolving Door of Cancer Care For Older Americans
美国老年人癌症护理的旋转门
  • 批准号:
    8327171
  • 财政年份:
    2011
  • 资助金额:
    $ 34.11万
  • 项目类别:
The Revolving Door of Cancer Care For Older Americans
美国老年人癌症护理的旋转门
  • 批准号:
    8180093
  • 财政年份:
    2011
  • 资助金额:
    $ 34.11万
  • 项目类别:
Family Evaluation of Hospice Care
临终关怀的家庭评估
  • 批准号:
    8019931
  • 财政年份:
    2010
  • 资助金额:
    $ 34.11万
  • 项目类别:
Family Evaluation of Hospice Care
临终关怀的家庭评估
  • 批准号:
    8140432
  • 财政年份:
    2010
  • 资助金额:
    $ 34.11万
  • 项目类别:
Family Evaluation of Hospice Care
临终关怀的家庭评估
  • 批准号:
    8298462
  • 财政年份:
    2010
  • 资助金额:
    $ 34.11万
  • 项目类别:
Effectiveness of Feeding Tubes Among Person with Advanced Cognitive Impairment
饲管对晚期认知障碍患者的有效性
  • 批准号:
    7938007
  • 财政年份:
    2009
  • 资助金额:
    $ 34.11万
  • 项目类别:
STATE POLICIES AND HEALTH SYSTEMS FACTORS ASSOCIATED WITH MULTIPLE TRANSITIONS
与多次转型相关的国家政策和卫生系统因素
  • 批准号:
    7190904
  • 财政年份:
    2007
  • 资助金额:
    $ 34.11万
  • 项目类别:
STUDY OF HOSPITALS STAFFING ATTENDING PHYSICIAN ROLE FOR PATIENTS AT END OF LIFE
医院人员在临终患者中扮演的角色研究
  • 批准号:
    9031025
  • 财政年份:
    2007
  • 资助金额:
    $ 34.11万
  • 项目类别:
STUDY OF HOSPITALS STAFFING ATTENDING PHYSICIAN ROLE FOR PATIENTS AT END OF LIFE
医院人员在临终患者中扮演的医生角色研究
  • 批准号:
    8618224
  • 财政年份:
    2007
  • 资助金额:
    $ 34.11万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 34.11万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 34.11万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 34.11万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 34.11万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 34.11万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 34.11万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 34.11万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 34.11万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 34.11万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 34.11万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了